STELLA PHARMA CORPORATION's total assets for Q3 2024 were ¥5.08B, a decrease of -2.46% from the previous quarter. JP:4888 total liabilities were ¥2.10B for the fiscal quarter, a -1.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.